Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Kawamura, Masashi ^a   Miyagawa, Shigeru ^a   Fukushima, Satsuki ^a   Saito, Atsuhiro ^b   Miki, Kenji ^a   Funakoshi, Shunsuke ^c   Yoshida, Yoshinori ^c   Yamanaka, Shinya ^c   Shimizu, Tatsuya ^d   Okano, Teruo ^d   Daimon, Takashi ^e   Toda, Koichi ^a   Sawa, Yoshiki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ANGIOGENESIS; ANIMAL; CARDIAC MUSCLE CELL; CELL CULTURE TECHNIQUE; CELL DIFFERENTIATION; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION; HEART MUSCLE ISCHEMIA; HUMAN; INDUCED PLURIPOTENT STEM CELL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PIG; STEM CELL TRANSPLANTATION;

ANIMALS; BIOMARKERS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION; SWINE;

EID: 85027842308     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-08869-z     Document Type: Article

References (36)

1. Menasché, P. & Vanneaux, V. Stem cells for the treatment of heart failure. Curr Res Transl Med. 64, 97-106 (2016).
2. Nguyen, P. K., Rhee, J. W. & Wu, J. C. Adult Stem Cell Therapy and Heart Failure, 2000 to 2016: A Systematic Review. JAMA Cardiol. 1, 1831-841 (2016).
3. Poulin, M. F., Deka, A., Mohamedali, B. & Schaer, G. L. Clinical Benefits of Stem Cells for Chronic Symptomatic Systolic Heart Failure: A Systematic Review of the Existing Data and Ongoing Trials. Cell Transplant. 25, 1911-1923 (2016).
4. Sawa, Y. & Miyagawa, S. Present and future perspectives on cell sheet-based myocardial regeneration therapy. Biomed Res Int. 2013, 583912 (2013).
5. Zvibel, I., Smets, F. & Soriano, H. Anoikis: roadblock to cell transplantation? Cell Transplant. 11, 621-30 (2002).
6. Memon, I. A. et al. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg. 130, 1333-1341 (2005).
7. Sekine, H. et al. Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection. Tissue Eng Part A. 17, 2973-2980 (2011).
8. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131, 861-872 (2007).
9. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 318, 1917-1920 (2007).
10. Yoshida, Y. & Yamanaka, S. iPS cells: a source of cardiac regeneration. J Mol Cell Cardiol. 50, 327-332 (2011).
11. Kawamura, M. et al. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation. 126, S29-S37 (2012).
12. Chandra, A. et al. The anti-inflammatory and antibacterial basis of human omental defense: selective expression of cytokines and antimicrobial peptides. PLoS One. 6, e20446 (2011).
13. Kawamura, M. et al. Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart. Circulation. 128, S87-94 (2013).
14. Uccelli, A., Moretta, L. & Pistoia, V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 8, 726-736 (2008).
15. Takebe, T. et al. Vascularized and Complex Organ Buds from Diverse Tissues via Mesenchymal Cell-Driven Condensation. Cell Stem Cell. 16, 556-5652 (2015).
16. Iseoka H et al. Pivotal Role of Non-cardiomyocytes in Electromechanical and Therapeutic Potential of Induced Pluripotent Stem Cell-Derived Engineered Cardiac Tissue. Tissue Eng Part A. Jun 13 (2017).
17. Teramoto, N. et al. Experimental pig model of old myocardial infarction with long survival leading to chronic left ventricular dysfunction and remodeling as evaluated by PET. J Nucl Med. 52, 761-768 (2011).
18. Tohyama, S. et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell. 12, 127-37 (2013).
19. Toyoda, K. et al. Effective magnetic labeling of transplanted cells with HVJ-E for magnetic resonance imaging. Neuroreport. 15, 589-93 (2004).
20. Miyoshi, S. et al. Transfection of neuroprogenitor cells with iron nanoparticles for magnetic resonance imaging tracking: cell viability, differentiation, and intracellular localization. Mol Imaging Biol. 7, 286-95 (2005).
21. Funakoshi, S. et al. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Sci Rep. 6, 19111 (2016).
22. Kainuma, S. et al. Cell-sheet therapy with omentopexy promotes arteriogenesis and improves coronary circulation physiology in failing heart. Mol Ther. 23, 374-386 (2015).
23. Chandra, A. et al. The anti-inflammatory and antibacterial basis of human omental defense: selective expression of cytokines and antimicrobial peptides. PLoS One. 6, e20446 (2011).
24. Penn, M. S. & Mangi, A. A. Genetic enhancement of stem cell engraftment, survival, and efficacy. Circ Res. 102, 1471-1482 (2008).
25. Jawad, H., Lyon, A. R., Harding, S. E., Ali, N. N. & Boccaccini, A. R. Myocardial tissue engineering. Br Med Bull. 87, 31-47 (2008).
26. Kehat, I. et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol. 22, 1282-1289 (2004).
27. Shiba, Y. et al. Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature. 489, 322-325 (2012).
28. Chong, J. J. et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature. 510, 273-277 (2014).
29. Shiba, Y. et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature. 538, 388-391 (2016).
30. Higuchi, T. et al. Functional and Electrical Integration of Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Myocardial Infarction Rat Heart. Cell Transplant. 24, 2479-2489 (2015).
31. Kawamura, T. et al. Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates. Stem Cell Reports. 6, 312-320 (2016).
32. Hatzistergos, K. E. et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res. 107, 913-922 (2010).
33. Bolli, R. et al. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation. 128, 122-131 (2013).
34. Le, T. Y., Thavapalachandran, S., Kizana, E. & Chong, J. J. New Developments in Cardiac Regeneration. Heart Lung Circ. 26, 316-322 (2017).
35. Kraitchman, D. L. et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 107, 2290-2293 (2003).
36. Cerqueira, M. D. et al. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 105, 539-542 (2002).